Cargando…
Polymorphisms in ADRB2 gene can modulate the response to bronchodilators and the severity of cystic fibrosis
BACKGROUND: The most common cystic fibrosis (CF) manifestation is the progressive chronic obstructive pulmonary disease caused by deficiency, dysfunction, or absence of the CFTR (Cystic Fibrosis Transmembrane Regulator) protein on the apical surface of the cells in the respiratory tract. The use of...
Autores principales: | Marson, Fernando A L, Bertuzzo, Carmen S, Ribeiro, Antônio F, Ribeiro, José D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558405/ https://www.ncbi.nlm.nih.gov/pubmed/22950544 http://dx.doi.org/10.1186/1471-2466-12-50 |
Ejemplares similares
-
Polymorphisms in the glutathione pathway modulate cystic fibrosis severity: a cross-sectional study
por: Marson, Fernando Augusto de Lima, et al.
Publicado: (2014) -
The ACE gene D/I polymorphism as a modulator of severity of cystic fibrosis
por: Marson, Fernando A L, et al.
Publicado: (2012) -
Personalized or Precision Medicine? The Example of Cystic Fibrosis
por: Marson, Fernando A. L., et al.
Publicado: (2017) -
Cystic fibrosis transmembrane conductance regulator
mutations at a referral center for cystic fibrosis
por: Coutinho, Cyntia Arivabeni de Araújo Correia, et al.
Publicado: (2013) -
Genetic interaction of GSH metabolic pathway genes in cystic fibrosis
por: Marson, Fernando Augusto de Lima, et al.
Publicado: (2013)